News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...


  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

Recent Postings



Roche (RHHBY) Anadys (ANDS) CompuGen (CGEN) Multiple Myeloma Amgen (AMGN) Velcade (bortezomib) Bellicum (BLCM) Merck (MRK) NOVOCURE (NVCR) Dendreon (DNDN) Alder Biopharmaceuticals (ALDR) Aimmune Therapeutics (AIMT) Inovio (INO) ISIS (ISIS) Spike Therapeutics (ONCE) Galena (GALE) JUNO (JUNO) Adaptimmune (ADAP) Theravance (THRX) Agenus (AGEN) VANDA (VNDA) galapagos (GLPG) Ionis (IONS) ImmunoGen (IMGN) IDERA (IDRA) Biocryst (BCRX) Prolor Biotech (PBTH) GlycoMimetics (GLYN) KITE (KITE) Global Cell Therapeutics (GBT) OncoCyte (OCX) Elan (ELN) Abbott Laboratories (ABT) ZALTRAP™ Sanofi (SNA) Zerenex C4 Therapeutics REGULUS (RGLS) Ocular Therapeutix (OCUL) AstraZeneca (AZN) Ridaforolimus CEMPRA (CEMP) ABBVIE (ABBV) ADVENTRIX (ANX) Editas (EDIT) NEUROCRINE (NBIX) Alnylam (ALNY) ARCA (ABIO) Incyte (INCY) Gilead (GILD) Advaxis (ADXS) Sequenom (SQNM) Human Longevity (HLI) Sanofi (SNY) GlaxoSmithKline (GSK) PTC Therapeutics (PTCT) Ariad (ARIA) Agenus (AGEN Intercept (ICPT) Xoma (XOMA) MODERNA Array Pharmaceuticals (ARRY) Dynavax (DVAX) Illumina (ILMN) SERES THERAPEUTICS (MCRB) Idenix (IDIX) Benlysta (belimumab) Vitae Pharmaceuticals (VTAE) Sangamo (SGMO) ARGOS (ARGS) Epizyme (EPZM) Pluristem (PSTI) Sarepta (SRPT) TOKAI (TKAOI) PORTOLA (PTLA) Ziofpharm (ZIOP) Roche (ROCHE) Herceptin NEKTAR (NKTR)) Endometrial Cancer SUNESIS PHARMACEUTICALS (SNSS) Trastuzumab-DM1 Tysabri JOUNCE THERAPEUTICS (JNCE) Jazz Pharmaceuticals (JAZZ) Akebia Therapeutics (AKAB) Prosensa (RNA) RenenxBio (RGNX) AGOS (ARGS) NANTKWEST (NK) GUARDIAN HEALTH HALOZYME (HALO) Sanofi-Aventis (SAN) Micromet (MITI) BIOMARIN (BMRN) AERIE PHARMACEUTICALS Intrexon (XON) Valeant Pharmaceuticals International (VRX) Biogen Idec (BIIB) Rapamune Revlimid (lenolidamide) Regeneron (REGN) Intermune (ITMN) Bristol-Myers Squibb (BMY) Vertex (VRTX) LEXICON (LXRX) INNOVIVA (INVA) Anacor (ANAC) Seattle Genetics (SGEN) Mirati Therapeutics (MRTX) CRISPR Therapeutics (CRSP) Exelixis (EXEL) Human Genome Sciences (HGSI) ACADIA (ACAD) Theravance Bio Pharma (TBPH) Onyx (ONXX) Genentech KERYX (KERX) Auspex (ASPX) SYNTA (SNTA) Cytokinetics (CYTK) OSI (OSIP) Telaprevir